TransMedics Group Statistics
Total Valuation
TMDX has a market cap or net worth of $3.84 billion. The enterprise value is $3.88 billion.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMDX has 34.30 million shares outstanding. The number of shares has increased by 15.12% in one year.
| Current Share Class | 34.30M |
| Shares Outstanding | 34.30M |
| Shares Change (YoY) | +15.12% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 3.39% |
| Owned by Institutions (%) | 109.84% |
| Float | 33.13M |
Valuation Ratios
The trailing PE ratio is 23.00 and the forward PE ratio is 44.42.
| PE Ratio | 23.00 |
| Forward PE | 44.42 |
| PS Ratio | 6.35 |
| Forward PS | 5.21 |
| PB Ratio | 8.12 |
| P/TBV Ratio | 8.37 |
| P/FCF Ratio | 28.78 |
| P/OCF Ratio | 19.94 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 28.82, with an EV/FCF ratio of 29.01.
| EV / Earnings | 20.37 |
| EV / Sales | 6.40 |
| EV / EBITDA | 28.82 |
| EV / EBIT | 35.69 |
| EV / FCF | 29.01 |
Financial Position
The company has a current ratio of 7.14, with a Debt / Equity ratio of 1.10.
| Current Ratio | 7.14 |
| Quick Ratio | 6.41 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 3.65 |
| Debt / FCF | 3.89 |
| Interest Coverage | 7.88 |
Financial Efficiency
Return on equity (ROE) is 54.24% and return on invested capital (ROIC) is 23.80%.
| Return on Equity (ROE) | 54.24% |
| Return on Assets (ROA) | 7.25% |
| Return on Invested Capital (ROIC) | 23.80% |
| Return on Capital Employed (ROCE) | 11.09% |
| Weighted Average Cost of Capital (WACC) | 13.46% |
| Revenue Per Employee | $674,269 |
| Profits Per Employee | $211,905 |
| Employee Count | 898 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 5.09 |
Taxes
| Income Tax | -82.77M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +62.32% in the last 52 weeks. The beta is 1.95, so TMDX's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +62.32% |
| 50-Day Moving Average | 133.82 |
| 200-Day Moving Average | 125.82 |
| Relative Strength Index (RSI) | 32.23 |
| Average Volume (20 Days) | 1,123,312 |
Short Selling Information
The latest short interest is 8.48 million, so 24.72% of the outstanding shares have been sold short.
| Short Interest | 8.48M |
| Short Previous Month | 8.23M |
| Short % of Shares Out | 24.72% |
| Short % of Float | 25.59% |
| Short Ratio (days to cover) | 10.29 |
Income Statement
In the last 12 months, TMDX had revenue of $605.49 million and earned $190.29 million in profits. Earnings per share was $4.87.
| Revenue | 605.49M |
| Gross Profit | 362.81M |
| Operating Income | 108.58M |
| Pretax Income | 107.52M |
| Net Income | 190.29M |
| EBITDA | 134.47M |
| EBIT | 108.58M |
| Earnings Per Share (EPS) | $4.87 |
Full Income StatementBalance Sheet
The company has $488.37 million in cash and $519.28 million in debt, with a net cash position of -$30.91 million or -$0.90 per share.
| Cash & Cash Equivalents | 488.37M |
| Total Debt | 519.28M |
| Net Cash | -30.91M |
| Net Cash Per Share | -$0.90 |
| Equity (Book Value) | 473.10M |
| Book Value Per Share | 13.81 |
| Working Capital | 548.48M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $192.84 million and capital expenditures -$59.25 million, giving a free cash flow of $133.59 million.
| Operating Cash Flow | 192.84M |
| Capital Expenditures | -59.25M |
| Depreciation & Amortization | 25.89M |
| Net Borrowing | n/a |
| Free Cash Flow | 133.59M |
| FCF Per Share | $3.89 |
Full Cash Flow StatementMargins
Gross margin is 59.92%, with operating and profit margins of 17.93% and 31.43%.
| Gross Margin | 59.92% |
| Operating Margin | 17.93% |
| Pretax Margin | 17.76% |
| Profit Margin | 31.43% |
| EBITDA Margin | 22.21% |
| EBIT Margin | 17.93% |
| FCF Margin | 22.06% |
Dividends & Yields
TMDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.12% |
| Shareholder Yield | -15.12% |
| Earnings Yield | 4.95% |
| FCF Yield | 3.47% |
Analyst Forecast
The average price target for TMDX is $154.00, which is 37.40% higher than the current price. The consensus rating is "Buy".
| Price Target | $154.00 |
| Price Target Difference | 37.40% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 18.13% |
| EPS Growth Forecast (5Y) | -2.37% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMDX has an Altman Z-Score of 4.77 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.77 |
| Piotroski F-Score | 7 |
